# OnCo record idea-hpv-ctdna-cervical (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-hpv-ctdna-cervical/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-hpv-ctdna-cervical" ;
  schema:name "HPV circulating tumour DNA to guide cervical cancer therapy"@en ;
  schema:description "Because cervical tumours carry viral DNA that normal cells do not, a blood test for HPV DNA is a near-perfect tumour marker for tracking response and relapse."@en ;
  schema:url <https://onco.cc/ideas/idea-hpv-ctdna-cervical/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04221945> ;
  onco:cancers <https://onco.cc/cancers/cervical/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/> ;
  onco:trials <https://onco.cc/trials/keynote-a18/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-a18-os-lancet-2024/>, <https://onco.cc/key-papers/paper-keynote-a18-pfs-lancet-2024/> .